bioRxivBioengineeringPreprint
Simple degradable cyclodextrin polyester with chelator-based crosslinker for stent-based drug delivery
K. Young, A. E. Lord, G. E. Burkhart, S. K. Kozawa, N. Mu, H. A. von Recum
Abstract
Cyclodextrins are a class of molecules which inclusion complexes with small hydrophobic drugs, and has historically been used to improve solubility and bioavailability of labile drugs in pharmaceutical applications. More recently, polymerized cyclodextrin has been applied in various applications as implantable drug delivery depots and as medical device coatings (e.g. polymeric hernia meshes) due to their ability to sustain and control drug delivery as well as prevent biofouling. Cyclodextrin polymers as coatings for metal medical devices, like screws or stents, is less explored; due to the high mechanical property mismatch between polymers and metals, a polymer coating is liable to delaminate easily, especially during device deformation. Novel methods for facilitating attachment to metal substrates have been explored, but coating longevity is still an issue, and these methods typically require the use of multiple reagents and complex methods. We report here the development and characterization of a cyclodextrin polymer with a chelator-based crosslinker with respect to appearance, chemistry, drug release profiles, erosion, pH-dependence. We found that increasing the crosslinking ratio (crosslinker:cyclodextrin) slowed down degradation and decreased drug loading as well. Drug release of the anti-restenotic drug sirolimus proceeded for over 4 weeks. The ability of the polymer to stably coat metal stents was verified, and the coating procedure is a simple, single step protocol.
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Cyclodextrin polymer coatings resist protein fouling, mammalian cell adhesion, and bacterial attachment
G. D. Learn, E. J. Lai, H. A. von Recum·bioRxiv·Jan 16, 2020
- Atlas drug-eluting coronary stents inhibits neointimal hyperplasia in sheep modeling
R. Dinc, H. Yerebakan·bioRxiv·Apr 19, 2023
- Doxycycline Release From Cyclodextrin Oligomer-Containing Collagen Gels
Eric Trout, Leena Palomo, … Steven J. Eppell·Journal of Controlled ReleasePeer-reviewed·May 5, 2026
- Camouflaging Endovascular Stents with an Endothelial Coat Using CD31 Domain 1-mimetic Peptides
J. Senemaud, C. Skarbek, … G. Caligiuri·bioRxiv·May 1, 2023
- Coil and flow diverting stents as drug delivery platforms for cerebral aneurysm treatment
John W. Thompson, Jennifer Suon, … Robert M Starke·bioRxiv·Jun 24, 2025
- Leveraging Affinity Interactions to Prolong Drug Delivery of Protein Therapeutics
A. B. Dogan, K. Dabkowski, H. von Recum·bioRxiv·Dec 3, 2020